203661-71-6 Usage
General Description
6-Boc-2-oxo-6-aza-spiro[3.4]octane is a chemical compound with the molecular formula C13H21NO4. It is a spirocyclic compound that contains a spiro[3.4]octane ring system. The "6-Boc" in its name indicates that there is a tert-butoxycarbonyl (Boc) protecting group attached to the sixth position of the molecule. The "2-oxo" signifies the presence of a ketone group at the second position, and the "6-aza" indicates the presence of a nitrogen atom at the sixth position. 6-Boc-2-oxo-6-aza-spiro[3.4]octane has potential applications in organic synthesis and medicinal chemistry as a building block for the synthesis of complex molecules or as a precursor for the development of pharmaceuticals.
Check Digit Verification of cas no
The CAS Registry Mumber 203661-71-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,0,3,6,6 and 1 respectively; the second part has 2 digits, 7 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 203661-71:
(8*2)+(7*0)+(6*3)+(5*6)+(4*6)+(3*1)+(2*7)+(1*1)=106
106 % 10 = 6
So 203661-71-6 is a valid CAS Registry Number.
203661-71-6Relevant articles and documents
CHEMICAL COMPOUNDS
-
Paragraph 0110-0112, (2021/04/02)
The present disclosure describes novel compounds, or their pharmaceutically acceptable salts, pharmaceutical compositions containing them, and their medical uses. The compounds of the disclosure have activity as Janus kinase (JAK) inhibitors and are useful in the treatment or control of inflammation, auto-immune diseases, cancer, and other disorders and indications where modulation of JAK would be desirable. Also described herein are methods of treating inflammation, auto-immune diseases, cancer, and other conditions susceptible to inhibition of JAK by administering a compound herein described.
HETEROAROMATIC COMPOUNDS AS BTK INHIBITORS
-
Paragraph 0113, (2014/03/21)
The present invention encompasses compounds of the formula (I) wherein the groups A, Cy, X1 and Y are defined herein, which are suitable for the treatment of diseases related to BTK, process of making, pharmaceutical preparations which contain compounds and their methods of use.
